Trials / Completed
CompletedNCT01019889
Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 480 (actual)
- Sponsor
- Korea Health Industry Development Institute · Other Government
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Socheongryong-tang (SCRT) and Yeongyopaedok-san (YPS) are effective in the treatment of upper respiratory tract infection.
Detailed description
Upper respiratory tract infections (URTIs) are the most prevalent disease of human beings, it incur a significant health burden on populations in terms of human suffering and economic losses. Usually, antibiotic therapy is not helpful since most infections are virally induced. Over 200 serologically different viral types are responsible for human URTIs, so that preventions of URTIs including vaccination are impassable. SCRT and YPS are widely used to treat the respiratory disease. The objective of this study is to determine the efficacy of SCRT and YPS in symptomatic relief of patients with URTIs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SCRT | 4 capsules,three times daily, for 7days or within symptom disappearance |
| DRUG | YPS | 4 capsules, three times daily, for 7days or within symptom disappearance |
| DRUG | Placebo | 4 capsules, three times daily, for 7days or within symptom disappearance |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-06-01
- Completion
- 2009-07-01
- First posted
- 2009-11-25
- Last updated
- 2012-04-06
Source: ClinicalTrials.gov record NCT01019889. Inclusion in this directory is not an endorsement.